Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (≥ 70 years of age)?

This publication has 10 references indexed in Scilit:

• Sequential or Alternating Doxorubicin and CMF Regimens in Breast Cancer With More Than Three Positive Nodes
  JAMA, 1995
• Use of tamoxifen for breast cancer: twenty-eight years later.
  Journal of Clinical Oncology, 1995
• The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up
  Annals of Oncology, 1994
• Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
  New England Journal of Medicine, 1994
• Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer.
  Journal of Clinical Oncology, 1994
• The Effect of Comorbidity on 3-Year Survival of Women with Primary Breast Cancer
  Annals of Internal Medicine, 1994
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
  The Lancet, 1992
• Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience.
  Journal of Clinical Oncology, 1989
• Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis.
  Journal of Clinical Oncology, 1989
• Adjuvant Therapy of Breast Cancer: A Southwest Oncology Group Experience
  Published by Springer Nature ,1984